Device Trial Radar · NCT05432232
The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Mar 23, 2023
Primary completion
Dec 28, 2024
Study completion Jun 6, 2025
Sponsor
- Lead sponsor
- HistoSonics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 27, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to evaluate the technical success and safety profile of the HistoSonics Investigational System for the treatment of primary solid renal tumors.
Conditions
- Renal Cancer
- Tumor, Solid
- Kidney Cancer
- Tumor
- Tumor, Benign
- Kidney Neoplasms
Interventions
HistoSonics Investigational SystemDevice
The HistoSonics Investigational System is intended for the non-invasive destruction of kidney tissue using histotripsy, a non-thermal mechanical process of focused ultrasound.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Effectiveness: Technical SuccessTime frame: Up to 36 hours after the index procedure
- Primary Safety: Freedom From Index Procedure Related Major ComplicationsTime frame: 30 days Post-Index Procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.